PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
07-Dec-2023 Enhanced Protection for Manufacturing Highly Potent Pharmaceuticals Introduced at New Jersey Facility Businesswire
07-Dec-2023 PlumCare and Fabric Genomics Announce a Strategic Partnership to Integrate the Fabric AI Platform with PlumCare’s FirstSteps™ Newborn Genome Screening Program in Greece Businesswire
07-Dec-2023 NextPoint Therapeutics Announces IND Clearance from the FDA to Advance NPX887, a Novel Therapeutic Targeting HHLA2 to Reactivate Exhausted T and NK Cells in HHLA2+ Solid Tumors Businesswire
07-Dec-2023 Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass Trial Evaluating the Safety and Efficacy of Belzupacap Sarotalocan (Bel-sar) for First-Line Treatment of Early-Stage Choroidal Melanoma Businesswire
07-Dec-2023 Global Cold Chain Monitoring Strategic Market Report 2023-2030: Food Security Concerns and Temperature-Sensitive Drugs to Propel Demand - ResearchAndMarkets.com Businesswire
07-Dec-2023 Komodo Health Adds 90M Closed Lives Per Year To Expansive Healthcare Map Businesswire
07-Dec-2023 Lobe Sciences Provides Update on L-130 Clinical Program Businesswire
07-Dec-2023 Shorla Oncology Welcomes Rayna Sethi Herman as Chief Commercial Officer Businesswire
07-Dec-2023 Bristol Myers Squibb Announces Phase 3 CheckMate -8HW Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) Compared to Chemotherapy in Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer Meets Primary... Businesswire
07-Dec-2023 Merck Announces KEYLYNK-008 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LYNPARZA® (olaparib) for Patients With Metastatic Squamous Non-Small Cell Lung Cancer to Stop for Futility Businesswire
07-Dec-2023 KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update Businesswire
07-Dec-2023 SEQSTER Launches CoRD™ (Connected Research & Development) Accelerating Drug Discovery and Deep Insights for Pharma Businesswire
07-Dec-2023 United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024 Businesswire
07-Dec-2023 Merck Announces Findings from Phase 2 KeyVibe-002 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab in Previously Treated Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) Businesswire
07-Dec-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
07-Dec-2023 Amanda Newton joins RWS’s Executive Team as President of Global Content Services Businesswire
07-Dec-2023 SpyBiotech Announces First Patient Dosed in Phase I Trial of SPYVLP01 Businesswire
07-Dec-2023 Second Annual Digital Engineering Awards Celebrate Corporate Giants and Visionary Engineers Businesswire
07-Dec-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Expensify, Inc. (EXFY) on Behalf of Investors Businesswire
07-Dec-2023 Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference Businesswire